Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits


escrs app advert yo advert


Search Title by author or title

Visual outcomes and patient satisfaction three and twelve months after implantation of a new refractive rotationally asymmetric multifocal intraocular lens

Poster Details

First Author: R. McNeely UNITED KINGDOM

Co Author(s):    E. Pazo   A. Nesbit   T. Moore   J. Moore           

Abstract Details


To assess the postoperative visual performance and subjective patient satisfaction following implantation of a rotationally asymmetric multifocal intraocular lens (IOL) 3 and 12 months postoperatively.


Cathedral Eye Clinic, Belfast, Northern Ireland, UK


The study enrolled 96 eyes of 55 patients implanted with the SBL-3 (Lenstec, Inc., Christ Church, Barbados) rotationally asymmetric multifocal IOL. Refraction, uncorrected (UDVA) and best-corrected (CDVA) distance visual acuities, uncorrected near (UNVA) and intermediate (UIVA) visual acuities, and a quality of vision (QOV) questionnaire to determine the subjective outcomes were evaluated preoperatively, and then 3 and 12 months postoperatively.


The mean monocular UDVA at 3 months was -0.02 ± 0.12 logMAR and 0 ± 0.12 logMAR 12 months postoperatively (P=0.15). The mean monocular UIVA was 0.39 ± 0.11 logMAR and 0.42 ± 0.11 logMAR at 3 months and 12 months respectively (P=0.01). The mean monocular UNVA was 0.13 ± 0.14 logMAR and 0.14 ± 0.13 logMAR at the respective postoperative assessments (P=0.68). The overall patient satisfaction (0 the worst to 10 the best) was 8.18 ± 1.28 at 3 months with a significant improvement at the second postoperative assessment where the overall QOV score was 8.87 ± 1.02 (P=0.001).


The new refractive multifocal IOL provides excellent vision at distance, intermediate and near at 3 and 12 months postoperatively. However, there is a significant improvement in subjective outcomes at the second postoperative assessment, where patients appear to neuroadapt reporting a significantly better overall QOV and less blurred vision.

Financial Disclosure:


Back to Poster listing